Andy DeFrancesco is the devil. Just ask anyone. The worst guy in the weed business, the archangel of bad asset deals, the shell master of Florida. He’s got investigative…
US MSOs
Curaleaf (CURA.C), the CSE-listed, U.S.-based multi-state operator (MSO), is now the target of several class-action lawsuits concerning the sale of products in violation of FDA regulations. Lawsuits by at…
Top tip: You guys out there whining about ‘the market’ being down are finding excuses for the wrong problem. Folks be running about with their hair on fire right…
A few years ago, we wrote one of our defining pieces at Equity.Guru, an article that opened a new world up for a variety of investors, and introduced them…
On July 22, 2019, the U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf Holdings (CURA.C) via overnight delivery. The message was plain: Four of the company’s CBD-infused…
Ianthus Capital (IAN.C) is diving headlong into repairing their rep by partnering with Dillard’s department stores, getting back to the business of business. CBD For Life, a subsidiary of…
On July 11, 2019, 3 Sixty Risk Solutions (SAFE.C) announced it would be offering its services to 1933 Industries (TGIF.C) to keep the company’s Nevada operations secure. This deal…
“There are times […] when even being right feels wrong. What do you say, for instance, about a generation that has been taught that rain is poison and sex…
Chemesis International (CSI.C) subsidiary, Natural Ventures, has signed a three year, USD$6M minimum purchase agreement with PR ONE, a medical cannabis company based in Puerto Rico. Over the deal’s three-year…
About eighteen months ago, National Access Cannabis (META.V) emerged as part II of the Chuck Rifici master plan of Canadian weed v2.0 domination. His v1.0 domination plan was a…